investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Johan Spetz
- CFO and Head of Investor Relations
- ir@sedanamedical.com
The Share
Press Releases
2025
2025-11-24 08:00
Sedana Medical AB (publ) announces that the company has completed its pre-NDA meeting with FDA and reached broad alignment with the Agency on the contents...
2025-10-24 07:00
Improved EBITDA performance amid Q3 market headwinds Third quarter 2025 January-September 2025 CEO comments Improved EBITDA performance amid Q3 market...
2025-10-16 18:00
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General...

